Zeiss Meditech Reports Accelerating Revenue Growth
Carl Zeiss Meditech AG reports that revenue for the previous nine months 2017/2108 increased by 7.1 percent to $1.389 billion CAD.
“As already announced in early July, given the positive revenue growth in the third quarter, the revenue forecast for fiscal year 2017/18 was increased slightly to €1,250m – €1,300m. I am particularly pleased that both Strategic Business Units in all regions once again contributed significantly to this. The positive development of our latest product innovations validates our strategy to further drive forward the development of innovative solutions in the medical sector and to further expand our global orientation,” said Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG, commenting on the result.
The ophthalmic devices business unit increased revenue by 6.4 percent, to $1021 million, while microsurgery revenue grew by 9.1 percent. The Americas region was the fastest growing at 11.7%, with a total revenue of $419 million.
Click here to read the full report.